Adaptimmune Corporate Office and R&D Facility

Milton Park, Oxfordshire

An element in the NHA-designed masterplan for MEPC at Milton Park, this purpose-built laboratory and office provides outstanding research facilities for Adaptimmune Therapeutics.

Adaptimmune is at the forefront of global interest in T-cell therapy, harnessing the body's own immune system to fight cancer. The pioneering company, which started up at Milton Park in 2008, has now expanded into a globally recognised business.

We designed both the shell-and-core and laboratory fit-out, organizing the accommodation around a first-floor atrium, which acts as a multi-purpose space for informal meetings and break-out, as well as social and corporate events.

An exciting new building, which will provide best-in-class laboratories to support the expansion of our R&D team and enable continuing progress with our research programs.
James Noble, CEO, Adaptimmune
This is great news for both Adaptimmune and the continuing development of Oxfordshire's thriving biotech industry and economy.
James Dipple, CEO, MEPC Milton Park

Our Team

  • Paul Baxter
  • Stephen Golding
  • Nicholas Langstaff
  • Rocio Anos
  • Chris Campion

Project Team

  • Client: MEPC UK
  • Client: Adaptimmune Ltd
  • Project Management: Ridge and Partners/MEPC
  • Cost Planning: Ridge and Partners
  • Structural Engineer: Glanville Consultants
  • Services Engineer: Hoare Lea
  • Landscape Architect: Gillespies LLP
  • Approved Inspector: Butler and Young
  • Contractor: Barnwood Construction Ltd.

Related